These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 17321595)

  • 1. Residual symptoms and recurrence during maintenance treatment of late-life depression.
    Dombrovski AY; Mulsant BH; Houck PR; Mazumdar S; Lenze EJ; Andreescu C; Cyranowski JM; Reynolds CF
    J Affect Disord; 2007 Nov; 103(1-3):77-82. PubMed ID: 17321595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which symptoms predict recurrence of depression in women treated with maintenance interpersonal psychotherapy?
    Dombrovski AY; Cyranowski JM; Mulsant BH; Houck PR; Buysse DJ; Andreescu C; Thase ME; Mallinger AG; Frank E
    Depress Anxiety; 2008; 25(12):1060-6. PubMed ID: 18781665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential benefits of slow titration of paroxetine treatment in an elderly population: eight-week results from a naturalistic setting.
    Gibiino S; Mori E; De Ronchi D; Serretti A
    J Clin Psychopharmacol; 2013 Aug; 33(4):565-9. PubMed ID: 23764690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which elderly depressed patients remain well on maintenance interpersonal psychotherapy alone?: report from the Pittsburgh study of maintenance therapies in late-life depression.
    Taylor MP; Reynolds CF; Frank E; Cornes C; Miller MD; Stack JA; Begley AE; Mazumdar S; Dew MA; Kupfer DJ
    Depress Anxiety; 1999; 10(2):55-60. PubMed ID: 10569127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speed of improvement in sleep disturbance and anxiety compared with core mood symptoms during acute treatment of depression in old age.
    Dombrovski AY; Blakesley-Ball RE; Mulsant BH; Mazumdar S; Houck PR; Szanto K; Reynolds CF
    Am J Geriatr Psychiatry; 2006 Jun; 14(6):550-4. PubMed ID: 16731725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy.
    Dombrovski AY; Lenze EJ; Dew MA; Mulsant BH; Pollock BG; Houck PR; Reynolds CF
    J Am Geriatr Soc; 2007 Sep; 55(9):1325-32. PubMed ID: 17767673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram in the treatment of anxiety symptoms associated with depression.
    Bandelow B; Andersen HF; Dolberg OT
    Depress Anxiety; 2007; 24(1):53-61. PubMed ID: 16937393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapse prevention and residual symptoms: a closer analysis of placebo-controlled continuation studies with escitalopram in major depressive disorder, generalized anxiety disorder, social anxiety disorder, and obsessive-compulsive disorder.
    Bech P; Lönn SL; Overø KF
    J Clin Psychiatry; 2010 Feb; 71(2):121-9. PubMed ID: 19961809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of continuation treatment on residual symptoms in late-life depression: how well is "well"?
    Opdyke KS; Reynolds CF; Frank E; Begley AE; Buysse DJ; Dew MA; Mulsant BH; Shear MK; Mazumdar S; Kupfer DJ
    Depress Anxiety; 1996-1997; 4(6):312-9. PubMed ID: 9166659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy.
    Bellino S; Zizza M; Rinaldi C; Bogetto F
    Can J Psychiatry; 2006 Jun; 51(7):453-60. PubMed ID: 16838827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial.
    Rucci P; Frank E; Scocco P; Calugi S; Miniati M; Fagiolini A; Cassano GB
    Depress Anxiety; 2011 Apr; 28(4):303-9. PubMed ID: 21308882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual symptoms in depressed patients after treatment with fluoxetine or reboxetine.
    Nelson JC; Portera L; Leon AC
    J Clin Psychiatry; 2005 Nov; 66(11):1409-14. PubMed ID: 16420078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual sleep disturbances in patients remitted from major depressive disorder: a 4-year naturalistic follow-up study.
    Li SX; Lam SP; Chan JW; Yu MW; Wing YK
    Sleep; 2012 Aug; 35(8):1153-61. PubMed ID: 22851811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual sleep beliefs and sleep disturbance following Cognitive Behavioral Therapy for major depression.
    Carney CE; Harris AL; Friedman J; Segal ZV
    Depress Anxiety; 2011 Jun; 28(6):464-70. PubMed ID: 21400641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors for recurrence of depression five years after short term psychodynamic therapy.
    Koppers D; Peen J; Niekerken S; Van R; Dekker J
    J Affect Disord; 2011 Nov; 134(1-3):468-72. PubMed ID: 21676466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of variability in residual symptoms with recurrence of major depressive disorder during maintenance treatment.
    Karp JF; Buysse DJ; Houck PR; Cherry C; Kupfer DJ; Frank E
    Am J Psychiatry; 2004 Oct; 161(10):1877-84. PubMed ID: 15465986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapy.
    Bauer M; McIntyre RS; Szamosi J; Eriksson H
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1755-65. PubMed ID: 23672772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.